CNBX Pharmaceuticals (QB) Stock Price

-0.13 (-4.06%)
Volume 656
Bid Price 3.07
Ask Price 5.15
News -
Day High 3.07


52 Week Range


Day Low 3.07
Company Name Stock Ticker Symbol Market Type
CNBX Pharmaceuticals Inc (QB) CNBX OTCMarkets Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.13 -4.06% 3.07 16:30:25
Open Price Low Price High Price Close Price Prev Close
3.07 3.07 3.07 3.07 3.20
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
12 656 $ 3.07 $ 2,014 - 0.0601 - 5.50
Last Trade Time Type Quantity Stock Price Currency
15:39:29 24 $ 3.12 USD


Draw Mode:

CNBX Pharmaceuticals Inc (QB) Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 3.86M 1.26M 482.54k $ - $ - - -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
35.55k $ - - - -

more financials information »

CNBX Pharmaceuticals (QB) News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical CNBX Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week2.753.202.753.041,1440.3211.64%
1 Month4.604.601.602.97738-1.53-33.26%
3 Months4.154.901.603.46681-1.08-26.02%
6 Months0.089855.500.0750.164695220,8672.983,316.81%
1 Year0.15115.500.06010.1107736111,1862.921,931.77%
3 Years0.206255.500.06010.2592846236,9482.861,388.48%
5 Years0.87255.500.06010.6106711246,5372.20251.86%

CNBX Pharmaceuticals (QB) Description

CNBX Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company specializing in the discovery, development and commercialization of novel cannabinoid-based products and innovative technologies for the treatment of cancer. We combine the power of our proprietary technologies with the expertise of our leading scientists to unlock the medicinal properties of cannabis and its diversity of bioactive compounds. We have conducted thousands of tests on biopsies and cell lines in order to identify the physiologic impact of cannabinoids on cell cycle and cell death. Our core technology is a continuously evolving bioinformatics platform that utilizes high throughput screening technology, advanced data analytics, artificial intelligence and proprietary methodologies to rapidly examine the physiologic impact of multiple cannabinoid compounds on tumor cells.

Your Recent History
CNBX Pharm..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to InvestorsHub
Register Now